Wai Yuen Tong Medicine Holdings Limited
HKEX:0897.HK
0.186 (HKD) • At close September 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 783.881 | 1,286.428 | 1,391.411 | 1,108.565 | 620.741 | 751.443 | 845.781 | 738.44 | 825.331 | 831.088 | 865.258 | 808.517 | 752.072 | 639.512 | 529.305 | 496.151 | 477.021 | 381.266 | 324.756 | 326.909 | 349.225 |
| Cost of Revenue
| 389.068 | 676.888 | 817.257 | 660.307 | 338.503 | 449.915 | 501.987 | 427.676 | 455.113 | 480.061 | 475.768 | 443.207 | 397.699 | 337.902 | 276.932 | 267.478 | 255.612 | 205.952 | 190.904 | 162.134 | 194.107 |
| Gross Profit
| 394.813 | 609.54 | 574.154 | 448.258 | 282.238 | 301.528 | 343.794 | 310.764 | 370.218 | 351.027 | 389.49 | 365.31 | 354.373 | 301.61 | 252.373 | 228.673 | 221.409 | 175.314 | 133.852 | 164.775 | 155.118 |
| Gross Profit Ratio
| 0.504 | 0.474 | 0.413 | 0.404 | 0.455 | 0.401 | 0.406 | 0.421 | 0.449 | 0.422 | 0.45 | 0.452 | 0.471 | 0.472 | 0.477 | 0.461 | 0.464 | 0.46 | 0.412 | 0.504 | 0.444 |
| Reseach & Development Expenses
| 1.786 | 1.897 | 1.302 | 4.972 | 10.843 | 7.902 | 15.705 | 8.389 | 6.494 | 2.633 | 0.692 | 0.837 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 108.855 | 265.092 | 252.171 | 261.057 | 171.508 | 166.17 | 185.839 | 172.403 | 150.54 | 135.219 | 108.022 | 102.345 | 88.083 | 101.123 | 79.46 | 97.788 | 87.332 | 64.922 | 76.785 | 84.084 | 97.328 |
| Selling & Marketing Expenses
| 246.123 | 256.399 | 234.626 | 155.163 | 216.729 | 281.769 | 267.344 | 263.861 | 292.666 | 272.684 | 259.493 | 243.348 | 222.157 | 180.689 | 162.526 | 153.494 | 0 | 118.004 | 0 | 0 | 0 |
| SG&A
| 352.147 | 544.607 | 516.658 | 467.256 | 405.804 | 448.665 | 455.51 | 436.264 | 443.206 | 407.903 | 367.515 | 345.693 | 310.24 | 281.812 | 241.986 | 251.282 | 87.332 | 182.926 | 76.785 | 84.084 | 97.328 |
| Other Expenses
| 7.914 | -11.483 | -0.031 | 0.646 | -0.03 | 9.203 | -5.156 | 7.852 | 2.652 | 2.527 | 2.78 | 34.939 | -232.597 | 51.551 | 10.342 | -26.984 | 64.347 | 0 | 105.168 | 127.107 | 88.021 |
| Operating Expenses
| 353.933 | 557.987 | 517.991 | 471.582 | 416.677 | 290.365 | 549.743 | 481.435 | 406.687 | 406.881 | 363.95 | 316.902 | 278.195 | 256.344 | 222.043 | 224.298 | 151.679 | 182.926 | 181.953 | 211.191 | 185.349 |
| Operating Income
| 40.88 | 51.553 | 56.163 | -23.324 | -134.439 | -147.137 | -111.716 | -125.5 | -72.988 | 16.274 | 83.379 | 112.138 | 76.178 | 45.266 | 30.093 | -12.043 | 69.73 | -7.612 | -48.101 | -41.143 | -27.869 |
| Operating Income Ratio
| 0.052 | 0.04 | 0.04 | -0.021 | -0.217 | -0.196 | -0.132 | -0.17 | -0.088 | 0.02 | 0.096 | 0.139 | 0.101 | 0.071 | 0.057 | -0.024 | 0.146 | -0.02 | -0.148 | -0.126 | -0.08 |
| Total Other Income Expenses Net
| -57.046 | -66.435 | -105.039 | -284.461 | 574.429 | 228.831 | -3.171 | 29.141 | 102.054 | 176.632 | 146.334 | 100.45 | -290.043 | 80.295 | 17.577 | -350.139 | 16.056 | 18.517 | -59.291 | -15.164 | 1.983 |
| Income Before Tax
| -16.166 | -14.882 | -48.876 | -307.785 | 439.99 | 81.694 | -114.887 | -96.359 | 29.066 | 120.778 | 171.874 | 148.858 | -213.865 | 125.561 | 47.907 | -345.764 | 85.786 | 10.905 | -107.392 | -61.58 | -28.248 |
| Income Before Tax Ratio
| -0.021 | -0.012 | -0.035 | -0.278 | 0.709 | 0.109 | -0.136 | -0.13 | 0.035 | 0.145 | 0.199 | 0.184 | -0.284 | 0.196 | 0.091 | -0.697 | 0.18 | 0.029 | -0.331 | -0.188 | -0.081 |
| Income Tax Expense
| -6.359 | -15.283 | 40.519 | 148.132 | 17.199 | 7.448 | 2.281 | 2.432 | 3.839 | 0.017 | 3.676 | 0.539 | 12.978 | 20.666 | 2.876 | 0.178 | 2.404 | 0.982 | -1.24 | 5.647 | 1.738 |
| Net Income
| -15.356 | -20.515 | -108.912 | -375.995 | 438.548 | 74.627 | -115.581 | -93.303 | 25.387 | 120.979 | 163.374 | 148.433 | -226.922 | 99.133 | 45.797 | -345.906 | 83.382 | 9.923 | -106.152 | -67.227 | -29.986 |
| Net Income Ratio
| -0.02 | -0.016 | -0.078 | -0.339 | 0.706 | 0.099 | -0.137 | -0.126 | 0.031 | 0.146 | 0.189 | 0.184 | -0.302 | 0.155 | 0.087 | -0.697 | 0.175 | 0.026 | -0.327 | -0.206 | -0.086 |
| EPS
| -0.013 | -0.017 | -0.088 | -0.31 | 0.36 | 0.06 | -0.091 | -0.11 | 0.083 | 0.45 | 0.84 | 1.16 | -1.89 | 1.3 | 1.38 | -74.46 | 22.05 | 3.01 | -32.18 | -8.15 | -414.5 |
| EPS Diluted
| -0.013 | -0.017 | -0.088 | -0.31 | 0.36 | 0.06 | -0.091 | -0.11 | 0.083 | 0.45 | 0.84 | 1.16 | -1.89 | 1.3 | 1.38 | -74.46 | 22.05 | 3.01 | -32.18 | -8.15 | -414.5 |
| EBITDA
| 130.052 | 164.602 | 163.96 | 69.299 | -21.765 | -95.814 | -64.903 | -111.046 | -58.089 | 99.751 | 152.34 | 166.006 | -197.75 | 137.904 | 90.207 | 299.893 | 87.717 | 8.315 | -32.664 | -36.208 | -9.067 |
| EBITDA Ratio
| 0.166 | 0.128 | 0.118 | 0.063 | -0.035 | -0.128 | -0.077 | -0.15 | -0.07 | 0.12 | 0.176 | 0.205 | -0.263 | 0.216 | 0.17 | 0.604 | 0.184 | 0.022 | -0.101 | -0.111 | -0.026 |